Talk about playing favorites.
A small drug company called TherapeuticsMD (TXMD) agreed to pay $200,000 to settle charges of illegally sharing material, non-public information with analysts after holding discussions with the Food and Drug Administration about a key medicine being developed.
About the Author Reprints
